[1] Evered L, Silbert B, Knopman D S, et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018[J]. Anesthesiology, 2018, 129(5): 872-879.
[2] Fang Q W, Qian X Y, An J X, et al. Higher dose dexamethasone increases early postoperative cognitive dysfunction[J]. J Neurosurg Anesthesiol, 2014, 26(3): 220-225.
[3] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders[M]. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
[4] Wang X H, Chen X L, Wu F, et al. Relationship between postoperative biomarkers of neuronal injury and postoperative cognitive dysfunction: a meta-analysis[J]. PLoS One, 2023, 18(4): e0284728.
[5] Moller J T, Cluitmans P, Rasmussen L S, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction[J]. Lancet, 1998, 351(9106):857-861.
[6] Vénéreau E, Ceriotti C, Bianchi M E. DAMPs from cell death to new life[J]. Front Immunol, 2015: 6: 422.
[7] Monk T G, Weldon B C, Garvan C W, et al. Predictors of cognitive dysfunction after major noncardiac surgery[J]. Anesthesiology, 2008, 108(1): 18-30.
[8] Witlox J, Eurelings L S, De Jonghe J F, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis[J]. JAMA, 2010, 304(4): 443-451.
[9] Brown C, Deiner S. Perioperative cognitive protection[J]. Br J Anaesth, 2016, 117(suppl 3): iii52-iii61.
[10] Ozalp Horsanali B, Ozkalkanli M Y, Tekgul Z T, et al. Effect of preoperative hospitalisation period on postoperative cognitive dysfunction in patients undergoing hip surgery under regional anaesthesia[J]. Int J Clin Pract, 2021, 75(5): e14032.
[11] Abdelkareem E, Tayee E M, Taha A M, et al. Effect of sevoflurane and isoflurane on post-anaesthesia cognitive dysfunction in normal and type II diabetic rats[J]. Arch Razi Inst, 2023, 78(1): 151-159.
[12] Le F H, Brouillette J, Fernandez-Gomez F J, et al. Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment[J]. Anesthesiology, 2012, 116(4): 779-787.
[13] Kamenskaya O V, Loginova I Y, Lomivorotov V V. Brain oxygen supply parameters in the risk assessment of cerebral complications during carotid endarterectomy[J]. J Cardiothorac Vasc Anesth, 2017, 31(3): 944-949.
[14] Bäckström D, Granåsen G, Mo S J, et al. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study[J]. Brain Commun, 2022, 4(2): fcac040.
[15] Dadar M, Gee M, Shuaib A, et al. Cognitive and motor correlates of grey and white matter pathology in Parkinson’s disease[J]. Neuroimage Clin, 2020, 27: 102353.
[16] Prikrylová Vranová H, Mareš J, Hluštík P, et al. Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease[J]. J Neural Transm, 2012, 119(3): 353-362.
[17] Mehanna R, Bajwa J A. Fernandez H, et al.Cognitive impact of deep brain stimulation on Parkinson's disease patients[J]. Parkinsons Dis, 2017, 2017: 3085140.
[18] Higashino Y, Isozaki M, Tsunetoshi K, et al. Factors affecting global neurocognitive status and frontal executive functions in the early stage after surgical clipping of unruptured anterior circulation aneurysms with respect to keyhole clipping and conventional clipping[J]. Acta Neurochir, 2022, 164(8): 2219-2228.
[19] Shen Y, Dong Z F, Pan P L, et al. Risk factors for mild cognitive impairment in patients with aneurysmal subarachnoid hemorrhage treated with endovascular coiling[J]. World Neurosurg, 2018, 119: e527-e533.
[20] Song Y, Zhou J X, Tan Y, et al. Risk factors and clinical significance of ultra-long-term microischemia after intracranial aneurysm embolization[J]. Neurol Ther, 2024, 13(4): 1173-1190.
[21] Fernandes M A, Hickle S D, Penna S, et al. Comparative analysis of cognitive and psychiatric functioning in people with Cushing’s disease in biochemical remission and people with nonfunctioning adenomas[J]. Behav Neurol, 2024, 2024(1): 4393169.
[22] Yang X J, Ewald E R, Huo Y Q, et al. Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5[J]. Biochem Biophys Res Commun, 2012, 420(3): 570-575.
[23] Vazquez S, Gold J, Spirollari E, et al. The story of dexamethasone and how it became one of the most widely used drugs in neurosurgery[J]. J Neurosurg, 2024, 140(4): 1191-1197.
[24] Gupta P, Khanna J, Mitramustafi A K, et al. Role of pre-operative dexamethasone as prophylaxis for postoperative nausea and vomiting in laparoscopic surgery[J]. J Minim Access Surg, 2006, 2(1): 12-15.
[25] Li P J, Qiao Y J, Zeng J K, et al. A systematic review and meta-analysis on the effects of intravenous dexamethasone on postoperative outcomes in patients undergoing total knee arthroplasty[J]. Langenbecks Arch Surg, 2025, 410(1): 49.
[26] Valentin L S, Pereira V F, Pietrobon R S, et al. Effects of single low dose of dexamethasone before noncardiac and nonneurologic surgery and general anesthesia on postoperative cognitive dysfunction-a phase III double blind, randomized clinical trial[J]. PLoS One, 2016, 11(5): e0152308.
[27] Glumac S, Kardum G, Sodic L, et al. Effects of dexamethasone on early cognitive decline after cardiac surgery: a randomised controlled trial[J]. Eur J Anaesthesiol, 2017, 34(11): 776-784.
[28] Clemmesen C G, Lunn T H, Kristensen M T, et al. Effect of a single pre-operative 125 mg dose of methylprednisolone on postoperative delirium in hip fracture patients; a randomised, double-blind, placebo-controlled trial[J]. Anaesthesia, 2018, 73(11): 1353-1360.
[29] Glumac S, Kardum G, Sodic L, et al. Longitudinal assessment of preoperative dexamethasone administration on cognitive function after cardiac surgery: a 4-year follow-up of a randomized controlled trial[J]. BMC Anesthesiol, 2021, 21(1): 129.
[30] Ottens T H, Dieleman J M, Sauër A M, et al. Effects of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial[J]. Anesthesiology, 2014, 121(3): 492-500.
[31] Li L Q, Wang C, Fang M D, et al. Effects of dexamethasone on post-operative cognitive dysfunction and delirium in adults following general anaesthesia: a meta-analysis of randomised controlled trials[J]. BMC Anesthesiol, 2019, 19(1): 113.
[32] Royse C F, Saager L, Whitlock R, et al. Impact of methylprednisolone on postoperative quality of recovery and delirium in the steroids in cardiac surgery trial: a randomized, double-blind, placebo-controlled substudy[J]. Anesthesiology, 2017, 126(2): 223-233.
[33] Galea I. The blood-brain barrier in systemic infection and inflammation[J]. Cell Mol Immunol, 2021, 18(11): 2489-2501.
[34] Sapolsky R M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders[J]. Arch Gen Psychiatry, 2000, 57(10): 925-935.
[35] Chen H, Lombès M, Le Menuet D. Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells[J]. Mol Brain, 2017, 10(1): 12.
[36] Wang Y Y, Li M Q, Tang J, et al. Glucocorticoids facilitate astrocytic amyloid-β peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-β-degrading proteases[J]. Endocrinology, 2011, 152(7): 2704-2715.
[37] Zeng K, Long J Y, Li Y, et al. Preventing postoperative cognitive dysfunction using anesthetic drugs in elderly patients undergoing noncardiac surgery: a systematic review and meta-analysis[J]. Int J Surg, 2023, 109(1): 21-31.
[38] Otawara Y, Ogasawara K, Kubo Y, et al. Comparison of postoperative cognitive function in patients undergoing surgery for ruptured and unruptured intracranial aneurysm[J]. Surg Neurol, 2009, 72(6): 592-595.
|